DE69032471D1 - Proteine mit onkostatin-m-aktivität und verfahren zu ihrer herstellung - Google Patents

Proteine mit onkostatin-m-aktivität und verfahren zu ihrer herstellung

Info

Publication number
DE69032471D1
DE69032471D1 DE69032471T DE69032471T DE69032471D1 DE 69032471 D1 DE69032471 D1 DE 69032471D1 DE 69032471 T DE69032471 T DE 69032471T DE 69032471 T DE69032471 T DE 69032471T DE 69032471 D1 DE69032471 D1 DE 69032471D1
Authority
DE
Germany
Prior art keywords
oncostatin
mutants
proteins
activity
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69032471T
Other languages
English (en)
Other versions
DE69032471T2 (de
Inventor
Peter Linsley
Jeffrey Kallestad
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of DE69032471D1 publication Critical patent/DE69032471D1/de
Publication of DE69032471T2 publication Critical patent/DE69032471T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
DE69032471T 1989-12-08 1990-12-07 Proteine mit onkostatin-m-aktivität und verfahren zu ihrer herstellung Expired - Fee Related DE69032471T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44775989A 1989-12-08 1989-12-08
US62386790A 1990-12-03 1990-12-03
PCT/US1990/007227 WO1991009057A1 (en) 1989-12-08 1990-12-07 Novel proteins with oncostatin m activity and process for their preparation

Publications (2)

Publication Number Publication Date
DE69032471D1 true DE69032471D1 (de) 1998-08-13
DE69032471T2 DE69032471T2 (de) 1999-03-04

Family

ID=27035080

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69032471T Expired - Fee Related DE69032471T2 (de) 1989-12-08 1990-12-07 Proteine mit onkostatin-m-aktivität und verfahren zu ihrer herstellung

Country Status (17)

Country Link
EP (1) EP0504291B1 (de)
JP (1) JPH05504134A (de)
KR (1) KR920703636A (de)
CN (1) CN1055389A (de)
AT (1) ATE168117T1 (de)
AU (1) AU651330B2 (de)
CA (1) CA2070171A1 (de)
DE (1) DE69032471T2 (de)
DK (1) DK0504291T3 (de)
ES (1) ES2120958T3 (de)
FI (1) FI104424B (de)
GR (1) GR3027654T3 (de)
IL (1) IL96593A0 (de)
NO (1) NO301769B1 (de)
NZ (1) NZ236382A (de)
PT (1) PT96134B (de)
WO (1) WO1991009057A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783672A (en) * 1994-05-26 1998-07-21 Immunex Corporation Receptor for oncostatin M
JPH09117288A (ja) * 1995-06-06 1997-05-06 Bristol Myers Squibb Co オンコスタチンｍ誘導造血
GB9806530D0 (en) 1998-03-26 1998-05-27 Glaxo Group Ltd Inflammatory mediator
US20120308517A1 (en) 2010-02-09 2012-12-06 Digna Biotech, S.L. Compositions for the treatment of infectious and tumoural diseases

Also Published As

Publication number Publication date
ATE168117T1 (de) 1998-07-15
NO922202L (no) 1992-06-04
CN1055389A (zh) 1991-10-16
KR920703636A (ko) 1992-12-18
EP0504291A1 (de) 1992-09-23
CA2070171A1 (en) 1991-06-09
ES2120958T3 (es) 1998-11-16
IL96593A0 (en) 1991-09-16
WO1991009057A1 (en) 1991-06-27
EP0504291B1 (de) 1998-07-08
AU651330B2 (en) 1994-07-21
AU7036191A (en) 1991-07-18
PT96134A (pt) 1991-09-30
EP0504291A4 (en) 1992-10-28
DE69032471T2 (de) 1999-03-04
JPH05504134A (ja) 1993-07-01
FI922612A (fi) 1992-06-05
FI922612A0 (fi) 1992-06-05
PT96134B (pt) 1998-04-30
DK0504291T3 (da) 1998-11-30
GR3027654T3 (en) 1998-11-30
FI104424B (fi) 2000-01-31
NO301769B1 (no) 1997-12-08
NZ236382A (en) 1992-08-26
NO922202D0 (no) 1992-06-04

Similar Documents

Publication Publication Date Title
GB8912330D0 (en) Live vaccines
ATE93270T1 (de) Verfahren zur herstellung einer stabilen bakteriellen zusammensetzung und verfahren zur brotbereitung unter verwendung dieser zusammensetzung.
DE3752372D1 (de) Verfahren zur regulierung der metabolischen stabilität von proteinen
DE3852823D1 (de) Transduktionsveränderte fibroblasten und ihre anwendung.
DE68929115T2 (de) Verfahren zur Herstellung von menschlichem Serumalbumin in Hefe
DE68929134D1 (de) Endothelin-DNA und Verwendung davon
FI90436B (fi) Ihmisen gammainterferonin kaltaisesti vaikuttavien polypeptidien valmistus
DK1200561T3 (da) Rekombinant stabil celleklon, dens fremstilling og anvendelse
DE69032471T2 (de) Proteine mit onkostatin-m-aktivität und verfahren zu ihrer herstellung
EP0315118A3 (de) Endothelin kodierendes DNA und dessen Verwendung
DK0757994T3 (da) TCF-mutanter
ES2052883T3 (es) Cultivo de celulas de riñon de cerdo y su uso en la produccion de vacunas.
ATE192191T1 (de) Methode zur verbesserten herstellung einer produzierende zellinie durch verwendung eines fusionsprotokolls

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee